Pulmonary Hypertension Clinical Trials in Durham, North Carolina

4 studies are recruiting for pulmonary hypertension in Durham, North Carolina right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    This is a prospective, real world, multicenter, registry of patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD) and interstitial lung disease (ILD).

    Stage
    Not phased
    Ages
    18 and older
    Site
    Duke University School of Medicine, Durham, North Carolina
    Locations
    71 in total
    Run by
    United Therapeutics

    See if you can join NCT06388421 on ClinicalTrials.gov

  2. Xenon MRI Pulm Hypertension

    The overall objective outlined in this study is to determine how pulmonary vascular remodeling in PAH at a cellular and pathological level is associated with changes in gas exchange physiology and hemodynamics (monitored with 129Xe MRI/MRS) and how these signals change with disease progression or t…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Duke University Medical Center, Durham, North Carolina
    Run by
    Bastiaan Driehuys

    See if you can join NCT04991454 on ClinicalTrials.gov

  3. 129 Xenon Imaging in Patients Treated With Sotatercept

    Determine the ability of 129Xe MRI/MRS biomarker signatures to non-invasively monitor pulmonary vascular reverse remodeling induced by sotatercept in pulmonary arterial hypertension (PAH).

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Duke University Medical Center, Durham, North Carolina
    Run by
    Bastiaan Driehuys

    See if you can join NCT06351345 on ClinicalTrials.gov

  4. Pulmonary Hypertension Association Registry

    The PHA Registry (PHAR) is a national study about people who have pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). PHAR collects information from people with PAH and CTEPH who are cared for in participating PHA-accredited Pulmonary Hypertension Care C…

    Stage
    Not phased
    Ages
    0 and older
    Site
    Duke University Medical Center, Durham, North Carolina
    Locations
    52 in total
    Run by
    Pulmonary Hypertension Association, Inc.

    See if you can join NCT04071327 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.